This study aimed to assess and compare the clinical efficacy and safety of a triple combination treatment using 2940 nm Er:YAG laser, triamcinolone acetonide solution combined with either 308 nm excimer laser or 0.1% tacrolimus for the treatment of stable segmental vitiligo. Patients with stable segmental vitiligo were randomly Vitiligo is one of the most common diseases involving skin and mucous membrane depigmentation, with an incidence of 1.0% globally. 1 It can occur throughout the body and affects all age groups. The etiology and pathogenesis of vitiligo remain unclear and, while easy to diagnose, it is difficult to treat. Vitiligo can be classifiied as segmental (SV) or non-segmental (NSV) vitiligo, while other forms include mixed vitiligo (segmental and non-segmental vitiligo) and unclassified vitiligo. 2 SV is relatively rare and characterized by the unilateral or zonal distribution of leukoplakia along certain nerve segments, an irregular shaped edge and there may be several pigment islands in the
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.